Iteris (ITI) said Wednesday it received stockholder approval for its proposed merger with Almaviva.
Under the terms of the all-cash deal, Almaviva will acquire Iteris for $7.20 per share, valuing the company at roughly $335 million.
The companies expect the deal to close on or about Nov. 1, after which Iteris will no longer be listed on any public market.
Price: 7.19, Change: -0.01, Percent Change: -0.07
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.